Ing Investment Management »

Bicara Therapeutics shares owned by Ing Investment Management

Quarter-by-quarter ownership of Bicara Therapeutics (BCAX) shares owned by Ing Investment Management from 13F filings

Historical chart of Ing Investment Management investment in Bicara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bicara Therapeutics held by Ing Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bicara Therapeutics by Ing Investment Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $306k 18k 16.83

More positions owned by Ing Investment Management

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Eli Lilly & Co. (LLY)
Tesla Motors (TSLA)
Wisdomtree Tr Voya Yld Enhncd (UNIY)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl C (GOOG)
Lam Research Corp Com New (LRCX)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Wells Fargo & Company (WFC)

View all positions for Ing Investment Management

Top funds holding Bicara Therapeutics

RA Capital Management
Siren
Vestal Point Capital
T. Rowe Price Investment Management
Red Tree Management
Tpg Gp A
FMR
Deep Track Capital
BlackRock
Omega Fund Management
Vanguard Group
State Street Corporation
Franklin Resources
Blackstone Group
Millennium Management

View all funds holding Bicara Therapeutics